Eterna Therapeutics
ERNA
6 hedge funds and large institutions have $499K invested in Eterna Therapeutics in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
56% less capital invested
Capital invested by funds: $1.13M → $499K (-$635K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$86.9K |
| 2 |
Jane Street
New York
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$434K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$404K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$50K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $253K | +$86.9K | +4 | +100% |
|
2
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $66K | – | – | – |
|
|
3
Jane Street
New York
| $48K | +$21.7K | +1 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $46K | – | – | – |
|
|
NSIM
5
North Star Investment Management
Chicago,
Illinois
| $42K | -$434K | -20 | -95% |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $36K | – | – | – |
|
7
BlackRock
New York
| $7K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
BA
9
Bard Associates
Chicago,
Illinois
| – | -$404K | -18 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$50K | -2 | Closed |
|
ERNA Hedge Fund Activity: Q2 2020 in Review
6 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2020, worth a combined $499K — down 56% from $1.13M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ERNA and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $86.9K. The largest seller was North Star Investment Management, cutting an estimated $434K.
- 6 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2020, down from 7 in Q1 2020.
- Funds reported $499K of Eterna Therapeutics stock for Q2 2020, down 56% quarter-over-quarter.
- 1 fund opened new Eterna Therapeutics positions in Q2 2020 and 2 closed out, a net change of -1 holder.
- The largest Eterna Therapeutics buyer in Q2 2020 was Renaissance Technologies, an estimated $86.9K added.
- The largest Eterna Therapeutics seller in Q2 2020 was North Star Investment Management, an estimated $434K sold.
Based on aggregated 13F filings for Q2 2020.